Rx Update: October 2002
Mary Ross, R.Ph., M.B.A., Barbara Mutnick, R.Ph., M.H.P., Joan
Murhammer, R.Ph.
Peer Review Status: Internally Reviewed
There have been a number of new insulin products introduced in the US for the treatment of diabetes. The onset, peak, and duration of action after subcutaneous injection of the newer products as compared to the other available insulin preparations are listed in the table below. The compatibility of the insulin mixes is also shown.
|
Insulin Type |
|
(hrs) |
(hrs) |
|
|
|
|
|||||
|
Aspart |
|
|
|
|
|
|
Lispro |
|
|
|
|
|
|
|
|||||
|
Regular |
Humulin R® Reg/Iletin II Pork® Velosulin® |
|
|
|
|
|
|
|||||
|
Isophane |
Novolin N® Humulin N® |
|
|
|
|
|
Lente |
Novolin L® |
|
|
|
|
|
|
|||||
|
Glargine |
|
|
|
|
|
|
Ultralente |
|
|
|
|
|
There are other important aspects to the dosing and administration of the newer insulins. These include: